Chinese Medicine Clinical Study Center, Jockey Club School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong SAR, China.
BGI Genomics, BGI-Shenzhen, Shenzhen, China.
Microbiome. 2018 Jun 14;6(1):107. doi: 10.1186/s40168-018-0492-6.
The gut microbiota is closely associated with gastrointestinal (GI) motility disorder, but the mechanism(s) by which bacteria interact with and affect host GI motility remains unclear. In this study, through using metabolomic and metagenomic analyses, an animal model of neonatal maternal separation (NMS) characterized by accelerated colonic motility and gut dysbiosis was used to investigate the mechanism underlying microbiota-driven motility dysfunction.
An excess of intracolonic saturated long-chain fatty acids (SLCFAs) was associated with enhanced bowel motility in NMS rats. Heptadecanoic acid (C17:0) and stearic acid (C18:0), as the most abundant odd- and even-numbered carbon SLCFAs in the colon lumen, can promote rat colonic muscle contraction and increase stool frequency. Increase of SLCFAs was positively correlated with elevated abundances of Prevotella, Lactobacillus, and Alistipes. Functional annotation found that the level of bacterial LCFA biosynthesis was highly enriched in NMS group. Essential synthetic genes Fabs were largely identified from the genera Prevotella, Lactobacillus, and Alistipes. Pseudo germ-free (GF) rats receiving fecal microbiota from NMS donors exhibited increased defecation frequency and upregulated bacterial production of intracolonic SLCFAs. Modulation of gut dysbiosis by neomycin effectively attenuated GI motility and reduced bacterial SLCFA generation in the colon lumen of NMS rats.
These findings reveal a previously unknown relationship between gut bacteria, intracolonic SLCFAs, and host GI motility, suggesting the importance of SLCFA-producing bacteria in GI motility disorders. Further exploration of this relationship could lead to a precise medication targeting the gut microbiota for treating GI motility disorders.
肠道微生物群与胃肠道(GI)运动障碍密切相关,但细菌相互作用和影响宿主 GI 运动的机制尚不清楚。在这项研究中,通过使用代谢组学和宏基因组学分析,使用以结肠运动加速和肠道菌群失调为特征的新生期母体分离(NMS)动物模型,研究了微生物群驱动运动功能障碍的机制。
结肠内过多的饱和长链脂肪酸(SLCFAs)与 NMS 大鼠增强的肠蠕动有关。十七烷酸(C17:0)和硬脂酸(C18:0)作为结肠腔中最丰富的奇数和偶数碳 SLCFAs,可以促进大鼠结肠肌肉收缩并增加粪便频率。SLCFAs 的增加与普雷沃氏菌、乳杆菌和alistipes 的丰度增加呈正相关。功能注释发现,细菌 LCFA 生物合成水平在 NMS 组中高度富集。假无菌(GF)大鼠接受 NMS 供体的粪便微生物群后,排便频率增加,结肠腔内细菌产生的 SLCFAs 增加。新霉素对肠道菌群失调的调节有效减弱了 NMS 大鼠的 GI 运动,并减少了结肠腔内细菌 SLCFA 的产生。
这些发现揭示了肠道细菌、结肠内 SLCFAs 和宿主 GI 运动之间以前未知的关系,表明产 SLCFA 细菌在 GI 运动障碍中的重要性。进一步探索这种关系可能会导致针对肠道微生物群的精确药物治疗 GI 运动障碍。